2022年

Jikuya R, Murakami K, Nishiyama A, Kato I, Furuya M, Nakabayashi J, Ramilowski JA, Hamanoue H, Maejima K, Fujita M, Mitome T, Ohtake S, Noguchi G, Kawaura S, Odaka H, Kawahara T, Komeya M, Shinoki R, Ueno D, Ito H, Ito Y, Muraoka K, Hayashi N, Kondo K, Nakaigawa N, Hatano K, Baba M, Suda T, Kodama T, Fujii S, Makiyama K, Yao M, Shuch BM, Schmidt LS, Linehan WM, Nakagawa H, Tamura T, Hasumi H：Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers.iScience,25(6):104463, 2022.

Karibe J, Kuroda S, Saito T, Ishibashi Y, Usui K, Takeshima T, Komeya M, Yumura Y: Monozygotic adult twins with nonmosaic Klinefelter syndrome with different results of sperm retrieval. Andrologia, 54(1):14266,2022.

Kawahara T, Kawai K, Kojima T, Nagumo Y, Sakka S, Kandori S, Negoro H, Mathis BJ, Maruo K, Miura K, Sakamoto N, Shinohara N, Yamashita S, Yonemori K, Kishida T, Ukimura O, Nishimura K, Kobayashi Y, Nishiyama H：Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors.Int J Urol,29(7):741-747.2022

Kawahara T, Miyoshi Y, Ninomiya S, Sato M, Takeshima T, Hasumi H, Makiyama K, Uemura H:Administration of radium-223 and the prognosis in Japanese bone metastatic castration-resistant prostate cancer patients． A large database study. Int J Urol.29:1079-1084,2022.

Koizumi M, Sato S, Yoshihara M, Nakamura Y, Terao H, Okubo Y, Washimi K, Yoshioka E, Yokose T, Kishida T, Koshikawa N, Miyagi Y：
Chronological Change in EPHA2 Protein Expression Is Associated With Recurrence of Bladder Cancer.Anticancer Research,42(12):5783-5794，2022．
 

Kishida T：Editorial Comment on A case of mediastinal teratoma with malignant transformation into angiosarcoma and relapse with multiple bone metastases that was cured by multidisciplinary treatment.IJU Case Rep,6(2):96,2022. 

Kishida T：Editorial Comment from Dr Kishida to Rare case of a patient with testicular torsion complicated by acute pneumonia, requiring emergency surgery, during the COVID-19 pandemic.　IJU Case Rep,5(2):102-103,2022．

Kishida T：Editorial Comment to Magnetic resonance imaging of in vitro urine flow in single and tandem stented ureters subject to extrinsic ureteral obstruction. Int J Urol,29(10):1227,2022. 

Miyoshi Y, Kawahara T, Uemura H:A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen < 10 ng/mL. BMC Cancer, 22(1):1169,2022.

Nirei T, Tabei T, Sakai N, Koh H, Yoshida M, Fujikawa A, Ito H, Tsutsumi S, Furuhata S, Noguchi S, Taguri M, Kobayashi K: Real-world date in elderly men from Yokosuka City 15 years after introducing prostate-specific antigen-based population screening. Mol Clin Oncol,16(2):1-7, 2022.

Noguchi T,Osaka K,Shibata Y,Koizumi M,Suzuki T,Kishida T,Okubo Y,Kameda Y: ADENOCARCINOMA OF THE RETE TESTIS WITH METASTASIS OF THE PENILE AND LUNG: A CASE REPORT. Nihon Hinyokika Gakkai Zasshi,113(2):78-81,2022.

Ohtake S, Makiyama K, Yamashita D, Tatenuma T, Yao M: Training on a virtual reality laparoscopic simulator improves performance of live laparoscopic surgery. Asian J Endosc Surg,15:313-319, 2022.  

Ohtake S, Makiyama K, Yamashita D, Tatenuma T, Yao M: Objective assessment of laparoscopic targeting skills using a Short-Time Power of Difference (STPOD) method. Int J Comput Assist Radiol Surg,17:1029-1037,2022. 

Saito T, Komeya M, Usui K, Kuroda S,Takeshima T ,Takashima K, Ikeda M, Kondo Y, Yumura Y: A case of obstructive azoospermia secondary to genitourinary tract infection caused by a   prostatic utricle cyst. Asian J Androl,24(5):558-559,2022.

Shibata Y, Osaka K, Noguchi T, Koizumi M, Suzuki T, Kishida T, Okubo Y: Long-term survival after robot-assisted partial nephrectomy of collecting (bellini) duct carcinoma: a case report. Japanese Journal of Endourology and Robotics,35:165-167,2022.

Takanashi M, Ito H,Fukazawa T,Shinoki R,Tabei T,Kawahara T,Kobayashi K:Predictive factors for the success of trial catheter removal for women with urinary retention. LUTS,15(1):4-10,2022．

Takamoto D, Sasaki H, Kataoka H, Kodama F, Higuchi H, Hirano T, Takada Y, Harada S, Harada H, Tanaka H：Successful immunomodulation in kidney transplant recipients with cytokine release syndrome after coronavirus disease.IJU Case Rep,5(5):373-377,2022.

Takeshima T, Karibe J, Saito T, Ishibashi Y, Usui K, Mori K, Kuroda S, Komeya M, Yumura Y: Effect of keishibukuryogan combined with tocopherol nicotinate on sperm parameters in patients with a varicocele. Int J Urol,29(2):165-169,2022. 

Takeshima T, Usui K, Kuroda S, Kawahara T, Komeya M, Teranishi J, Uemura H, Yumura Y: Microsurgical varicocelectomy for intratesticular varicocele with a history of orchiopexy for undescended testis.IJU Case Rep,5(5):393-396,2022.

Tatenuma T, Ito H, Muraoka K, Ito Y, Hasumi H, Hayashi N, Kondo K, Nakaigawa N, Makiyama K:Roughness of the renal tumor surface could predict the surgical difficulty of robot-assisted partial nephrectomy. Asian J Endosc Surg,15(3):591-598,2022.

Uemura H, Arai G, Uemura H, et al:Safety and efficacy of apalutamide in Japanese patients with metastatic castration-sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo-controlled, phase III TITAN study.Int J Urol,29(6):533-540,2022.

Uemura H, Kobayashi K, et al:Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study. Int J Clin Oncol,27(10):1632-1643,2022. 

Uemura H, Matsumoto R, Uemura H, et al:Treatment strategies and outcomes in a long-term registry study of patients with high-risk metastatic hormone-naïve prostate cancer in Japan: An interim analysis of the J-ROCK study.Int J Urol,29(9):1061-1070,2022.

Ueno D, Vasquez JC, Sule A, Liang J, van Doorn J, Sundaram R, Friedman S, Caliliw R, Ohtake S, Bao X, Li J, Ye H, Boyd K, Huang RR, Dodson J, Boutros P, Bindra RS, Shuch B:Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-Dose alkylating chemotherapy. Oncotarget,13:1054-1067,2022.

Yumura Y, Takeshima T, Komeya M, Kuroda S, Saito T, Karibe J: Fertility and sexual dysfunction in young male cancer survivors. Reprod Med Biol,21(1):e12481,2022.

​

伊藤悠城，槙山和秀，小林一樹：【前立腺肥大症（BPH）の手術療法-臨床現場の本心】　術式の本心 すぐ導入したくなるTUVP.臨床泌尿器科,76(9)：612－615,2022．

上村博司:進化する転移性去勢感受性前立腺がん治療.日本排尿機能学会誌,33(1):195,2022.
 

苅部樹里衣, 小林幸太, 米山脩子, 藤川直也, 滝沢明利:腎細胞癌に対する根治的腎摘除後の残存尿管に尿管癌が発生した1例.泌尿器外科,35(6):541-543,2022.
 

苅部樹里衣, 横井勇毅, 山下大輔, 米山脩子, 滝沢明利:腰椎後方椎体間固定術後の気胸合併左尿管結石に対して脊椎麻酔下に
経皮・経尿道同時内視鏡手術で加療し得た1例.日本泌尿器内視鏡・ロボティクス学会, 35(2):323-325, 2022.
 

苅部樹里衣, 横井勇毅, 山下大輔, 米山脩子, 滝沢明利:尿路結石症に対する経皮・経尿道同時内視鏡手術(ECIRS)でのClearPetra治療成績.日本泌尿器内視鏡・ロボティクス学会, 35(2):256-260, 2022.

小林一樹，伊藤悠城，三山　健：ロボット支援前立腺全摘術導入による治療成績の変化の検討．共済医報,71(2)：184－189,2022．
 

篠木理沙，伊藤悠城，深澤武史，滝澤弘樹，佐野　太，小林一樹：光選択的前立腺レーザー蒸散術の治療成績に, 術者の経尿道的前立腺切除術の経験症例が与える影響．排尿機能学会誌，32(2)：441-446,2022

鈴木孝尚, 岸田　健, 高草木陽介, 西元　健, 長坂拓学, 近藤拓也, 小泉充之, 寺尾秀行, 土田圭祐, 加藤弘之, 鎌田　正: 前立腺癌に対する重粒子線治療後の尿路合併症についての検討. 日本排尿機能学会誌, 32:447-451,2022．

竹島徹平:思春期男子のヘルスケア　精子　プレコンセプションケアの立場から.思春期学, 40(1):25-31,2022.

田部井 正：前部尿道狭窄に対する代用組織を利用したonlay法による一期的尿道形成術.臨床泌尿器科,76:20-25,2022.

 

仁禮 卓磨，大内 秀紀：膀胱癌に対するＢＣＧ膀胱内注入療法後に生じた精嚢・精管における結核性膿瘍の１例.泌尿器外科,35:252-257,2022．
 

仁禮卓磨，日置茉莉，横溝由美子，大内秀紀：副腎オンコサイトーマの一例.泌尿器外科,35:534-536,2022.
 

仁禮卓磨，日置茉莉，横溝由美子，大内秀紀，諏訪 裕：術前MRIが有用であった陰茎折症の一例.泌尿器外科,35：1009-1012,2022.
 

野口毅朗, 逢坂公人, 柴田洋佑, 小泉充之, 鈴木孝尚, 岸田 健, 大久保陽一郎, 亀田陽一: 陰茎・肺転移を認めた精巣腺癌の1 例.日本泌尿器科学会雑誌,113:78-81, 2022.

野口毅朗, 鈴木孝尚, 柴田洋佑, 小泉充之, 逢坂公人, 大久保陽一郎, 佐藤慎哉, 横瀬 智之, 亀田陽一, 宮城洋平, 岸田 健:前立腺針生検から前立腺全摘除術施行までの待機期間とGleason scoreのup gradeの関係性についての検討.泌尿器外科,35(臨) 35,2022.
 

山下大輔, 岩佐絵連, 苅部樹里衣, 横井勇毅, 米山脩子, 滝沢明利, 光谷俊幸：右低形成腎に膀胱内尿管瘤を合併した成人男性の１例.泌尿器外科,35(3):247-251,2022．
 

横川秀平，田部井正，山口克哉，堤壮吾，今野真思，三山健，伊藤悠城，小林一樹：当院でのロボット支援前立腺全摘除術における
 

術後アセトアミノフェン定時静脈・経口投与の効果の検討.日泌尿会誌,113(3):103－109,2022．
 

吉田　実:特発性血小板減少性紫斑病に対してシクロフォスファミドを投与中に発症した出血性膀胱炎に加味帰脾湯が奏効した1例.日本東洋医学雑誌,73:293-296,2022.
 

米澤光祐, 寺西淳一, 森川知治, 齋藤智樹, 山本 章太郎, 花井孝宏, 石田寛明, 河原崇司, 三好 康秀, 上村 博司:多発転移に対してパゾパニブおよび
放射線治療後に腎腫瘍が切除可能になった1例. 泌尿器外科,35(10):1091-1094,2022.